Virus-Like Particle & Nano-Particle Vaccines

20-22 June 2022, University of Latvia, Riga, Latvia

  • Increase font size
  • Default font size
  • Decrease font size

Day Three

Provisional Conference Programme | Wednesday 22nd June 2022

Session 8:

Moderator to be confirmed

‘Self-emulsifying adjuvant systems (SE-AS) containing alpha-tocopherol show comparable immune responses to AS03’
Rushit N. Lodaya1, Mansoor M. Amiji2 and Derek T. O’Hagan1
(1 GSK, Slaoui Centre for Vaccines Research, Rockville, Maryland, USA; 2 Northeastern University, Department of Pharmaceutical Sciences, Boston, Massachusetts USA)

‘Bioengineering rabbit hemorrhagic disease virus capsid to generate a multivalent immune response against foreign B-cell epitopes’
María Zamora-Ceballos, Noelia Moreno, Jose R.Castón, Alí Alejo, Esther Blanco and Juan Bárcena
(Centro de Investigación en Sanidad Animal (CISA-INIA), Valdeolmos, Madrid, Spain)

‘VLP vaccine against influenza’
Anna Kirsteina
(University of Latvia, Riga, Latvia)

Coffee Break & Posters Breakdown

LATEBREAKER Presentations

Moderator: To be confirmed

‘Nano-flow cytometry: A platform for comprehensive virus and extracellular vesicle analysis’
Dimitri Aubert
(NanoFCM, Medicity, Nottingham, UK)

Latebreaker abstracts for oral and poster presentation at VLPNPV 2021 are called for.

Authors interested in submitting latebreaker abstracts should submit them directly to John Herriot at Meetings Management (VLPNPV 2021 Secretariat).

Closing date for latebreaker submissions is Friday 28th May 2021

* This provisional programme is correct at the time of publication. However the organizers reserve the right to make any alterations that may be required in the interests and integrity of the conference programme.


VLPNPV 2022 Delegates

Login details will be supplied after you have registered for the event.

VLPNPV 2022 Sponsors

  • NanoFCM
  • John Innes Centre
  • Anovasia
  • Mymetics
  • Croda
  • Medigen

VLPNPV 2022 Mailing List

E-mail Address
What is 3+2-1?